Treatment of Psoriasis Vulgaris with Oral 1α,25‐Dihydroxyvitamin D3

E-ISSN： 1346-8138|14|1|59-62

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.14, Iss.1, 1987-02, pp. : 59-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1α,24R‐Dihydroxyvitamin D3 Has an Ability Comparable to That of 1α,25‐Dihydroxyvitamin D3 to Induce Keratinocyte Differentiation

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 11, 1990-11 ,pp. : 707-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of 1α,25-Dihydroxyvitamin D₃ in Normal Mice after Systemic Exposure to Effective and Safe Antitumor Doses

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

Effects of 1α,25‐Dihydroxyvitamin D3 on the Transglutaminase Activity of Transformed Mouse Epidermal Cells in Culture

THE JOURNAL OF DERMATOLOGY, Vol. 16, Iss. 1, 1989-02 ,pp. : 7-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

1α,25-Dihydroxyvitamin D₃ Attenuates Platelet Activation and the Expression of VCAM-1 and MT1-MMP in Human Endothelial Cells

Cardiology, Vol. 118, Iss. 2, 2011-05 ,pp. : 107-115

Karger

Access to resources Recommend Favorite

1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor

International Journal of Molecular Medicine, Vol. 36, Iss. 4, 2015-01 ,pp. : 967-974

Spandidos Publications

Access to resources Recommend Favorite